G protein-coupled receptor (GPCR) gene variants and human genetic disease

Summary

This critical review synthesises current knowledge on G protein-coupled receptor gene variants and their role in human genetic disease. The authors examine both rare monogenic conditions (such as familial progressive myoclonus epilepsy caused by orphan receptor variants) and more common pharmacogenetic variants, establishing a framework for understanding GPCR variation across the disease spectrum. The work suggests that investigation of GPCR variants in Mendelian disorders provides a basis for interpreting the clinical significance of more prevalent variants of relevance to drug response.

Regional applicability

This is a fundamental molecular genetics review without regional specificity to United Kingdom farming or food systems. The findings have broad clinical applicability to genetic disease diagnostics and pharmacogenomics globally, including within United Kingdom healthcare and pharmaceutical contexts, but do not directly address agri-food system outcomes.

Key measures

GPCR gene variant characterisation; associations with monogenic phenotypes and pharmacogenetic outcomes

Outcomes reported

The study examined the role of G protein-coupled receptor (GPCR) gene variants in human genetic disease, with emphasis on monogenic Mendelian phenotypes and their pharmacogenetic significance. The research identified orphan receptor gene variants associated with rare familial progressive myoclonus epilepsy.

Topic tags